Erik Greb

Erik Greb joined the staff of Neurology Reviews in January 2012. Since then, he has attended scientific conferences, conducted video interviews, and written about clinical research in multiple sclerosis, epilepsy, Parkinson's disease, Alzheimer's disease, stroke, and other neurologic disorders. In addition to news articles, Erik has written investigative stories about multiple sclerosis, headache, and epilepsy. He previously wrote about pharmaceutical manufacturing, drug formulation and delivery, quality assurance, and regulation for Pharmaceutical Technology.

News

Galcanezumab benefits patients with migraine and medication overuse

Author:: Erik Greb

Publish date: August 22, 2019

PHILADELPHIA – The monoclonal antibody effectively reduces the number of monthly migraine headache days and decreases...

News

Can dietary therapies treat GERD effectively?

Author:: Erik Greb

Publish date: August 21, 2019

CHICAGO – Modifying diet can reduce the number of reflux events and affect tissue permeability, but some patients req...

News

Two genetic variants modify risk of Alzheimer’s disease

Author:: Erik Greb

Publish date: August 14, 2019

Common variants in the microglia-specific MS4A gene cluster modify risk for late-onset Alzheimer’s disease and modulate extracellular soluble TREM2...

News

Serum neurofilament light chain level may indicate MS disease activity

Author:: Erik Greb

Publish date: August 14, 2019

The biomarker is associated with brain atrophy, and changes in sNfL level are associated with disability worsening.

News

Lasmiditan is associated with driving impairment

Author:: Erik Greb

Publish date: August 13, 2019

PHILADELPHIA – Impairment is detected at 1.5 hours after dosing and is resolved by 8 hours after dosing.

News

Treatment of episodic cluster headache deviates from recommendations

Author:: Erik Greb

Publish date: August 13, 2019

PHILADELPHIA – Among patients with episodic cluster headache, use of acute medications is high, but use of preventive...

News

What is the future of celiac disease management?

Author:: Erik Greb

Publish date: August 13, 2019

CHICAGO – Investigators are studying new drugs, as well as existing treatments for other indications, as potential me...

News

CDC finds that too little naloxone is dispensed

Author:: Erik Greb

Publish date: August 6, 2019

Despite increases in the number of naloxone prescriptions dispensed, many patients at risk for overdose are not offered the potentially life-saving...

News

Vaccination is not associated with increased risk of MS

Author:: Erik Greb

Publish date: August 6, 2019

Data indicate an association between vaccination and lower likelihood of incident MS, but do not support conclusions about whether vaccination has ...

News

Researchers examine potential causes of dementia in CTE

Author:: Erik Greb

Publish date: August 6, 2019

More years of football play were associated with white matter changes and tau accumulation, which were associated with increased risk of dementia.<...

News

Posttraumatic headache may be associated with reduced pain thresholds

Author:: Erik Greb

Publish date: August 1, 2019

PHILADELPHIA – Symptoms of photophobia and allodynia are more severe in patients with posttraumatic headache, compare...

News

Exposure to patients with migraine increases likelihood of stigmatizing attitudes

Author:: Erik Greb

Publish date: July 31, 2019

PHILADELPHIA – An analysis of survey data raises questions about how to combat negative attitudes toward patient...

News

Exposure to synthetic cannabinoids is associated with neuropsychiatric morbidity in adolescents

Author:: Erik Greb

Publish date: July 19, 2019

Compared with adolescents exposed to cannabis alone, those exposed to synthetic cannabinoids alone had greater risk of CNS depression and seizures....